- Home
- OKE vs KVUE Comparison
OKE vs KVUE Comparison
Compare OKE & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKE
- KVUE
- Stock Information
- Founded
- OKE 1906
- KVUE 2022
- Country
- OKE United States
- KVUE United States
- Employees
- OKE N/A
- KVUE N/A
- Industry
- OKE Oil & Gas Production
- KVUE Specialty Chemicals
- Sector
- OKE Utilities
- KVUE Consumer Discretionary
- Exchange
- OKE Nasdaq
- KVUE Nasdaq
- Market Cap
- OKE 50.1B
- KVUE 41.0B
- IPO Year
- OKE N/A
- KVUE 2023
- Fundamental
- Price
- OKE $73.28
- KVUE $21.49
- Analyst Decision
- OKE Buy
- KVUE Buy
- Analyst Count
- OKE 14
- KVUE 12
- Target Price
- OKE $104.43
- KVUE $24.38
- AVG Volume (30 Days)
- OKE 3.7M
- KVUE 18.5M
- Earning Date
- OKE 08-04-2025
- KVUE 08-07-2025
- Dividend Yield
- OKE 5.64%
- KVUE 3.89%
- EPS Growth
- OKE 10.75
- KVUE 28.77
- EPS
- OKE 5.12
- KVUE 0.74
- Revenue
- OKE $27,953,000,000.00
- KVUE $15,141,000,000.00
- Revenue This Year
- OKE $41.46
- KVUE $2.34
- Revenue Next Year
- OKE $5.25
- KVUE $3.56
- P/E Ratio
- OKE $14.27
- KVUE $28.51
- Revenue Growth
- OKE 46.36
- KVUE N/A
- 52 Week Low
- OKE $72.90
- KVUE $19.75
- 52 Week High
- OKE $118.07
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- OKE 31.56
- KVUE 44.82
- Support Level
- OKE $73.02
- KVUE $20.97
- Resistance Level
- OKE $75.53
- KVUE $21.96
- Average True Range (ATR)
- OKE 1.78
- KVUE 0.56
- MACD
- OKE -0.42
- KVUE -0.07
- Stochastic Oscillator
- OKE 4.32
- KVUE 26.71
About OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.